Text Size decrease text size increase text size
 
News
Exhibitions
Clinical Data
Updates
Useful Links
search
Text Size decrease text size increase text size
Home  /  News  /  Updates  /  
Direx Announces Saudi FDA Approval for Renova

May. 1, 2017

Direx announced today that it has received approval from the Saudi Food and Drug Administration (SFDA) to market its Renova system in Saudia Arabia for the treatment of Erectile Dysfunction.

Renova is currently the only fully approved device offering shockwave therapy for patients suffering from ED. "Considerable interest has been expressed by local physicians who are eager to offer this treatment to their patients" noted the local representative. 

Renova will be presented at the upcoming Middle East Society of Sexual Medicine (MESSM), to take place September 14-16, in Abu Dhabi, UAE.

 

About DirexGroup:
DirexGroup specializes in introducing innovative high-technology devices for urologists in all worldwide markets. DirexGroup, established over 30 years ago, has continuously extended its worldwide presence in numerous countries and markets. DirexGroup has put its emphasis on the field of urology and offers urologists and medical centers various equipment and service solutions to their clinical and economic needs. Our products are characterized by reliability, modularity and transportability combined with cost effectiveness and ease of use. A worldwide network of committed service centers assures competent support and maintenance. Contact DirexGroup at: info@direxgroup.com